---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-089436"
form_type: "8-K"
ticker: "BTAI"
cik: "0001720893"
company_name: "BioXcel Therapeutics, Inc."
filed_at: "2026-08-03T11:00:23+00:00"
generated_at: "2026-08-03T11:05:43.493378+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# BioXcel defers $9M payment to Aug 31, cuts liquidity covenant to $6.25M

## Summary
- Deferred $9,016,914.47 principal+interest due June 30 to Aug 31, 2026.
- Minimum liquidity covenant reduced from $7.5M to $6.25M.
- Must enter definitive agreements for acceptable transaction by Aug 10, 2026.
- Prohibited from modifying compensation arrangements through Aug 31, 2026.
- Oaktree lenders agreed to these amendments.

## SEC filing metadata
- accession: 0001104659-26-089436
- form_type: 8-K
- ticker: BTAI
- cik: 0001720893
- company_name: BioXcel Therapeutics, Inc.
- filed_at: 2026-08-03T11:00:23+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1720893/000110465926089436/0001104659-26-089436-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1720893/000110465926089436/tm2622012d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-089436
- JSON: https://secwatch.observer/filing/0001104659-26-089436.json
- Plain text: https://secwatch.observer/filing/0001104659-26-089436.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.